In October of last year, Blackmores advised the market that, despite first quarter sales [for the financial year] being impacted by changes in market dynamics in Australia, the company has seen improved sales and profits from the second quarter with significant new sales being captured in China.
Last quarter’s net profits were down by almost half on the 2014-15 financial year but it has to be remembered that the previous year was exceptional for Blackmores meaning that comparatives would be tough.
The company’s strategy of exporting to China and SE Asia is long-standing and I see no reason why long term success for the sale of its core products of vitamins and herbal/mineral nutritional supplements here and overseas is being impeded in anyway.
The current dividend yield is a fully-franked 3.5%, and given the company’s long track record of increasing its revenue, earnings-per-share and dividends (over time), this company’s stock should be considered for any investor seeking growing income.
However, if you’re looking to buy shares soon, I’d first wait until after the company’s half-year profit announcement has been released to the market.